Skip to main content
Erschienen in: Cancer Causes & Control 8/2009

01.10.2009 | OriginalPaper

Investigating reversals of association for utilization of recent mammography among Hispanic and Non-Hispanic Black women

verfasst von: William Rakowski, Melissa A. Clark, Michelle L. Rogers, Sherry Weitzen

Erschienen in: Cancer Causes & Control | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective

Several papers have found that Hispanic and Non-Hispanic Black women have higher adjusted odds ratios for recent mammography when compared with Non-Hispanic White women, even though their crude percentages were lower than, or about equal to, Non-Hispanic White women’s. This paper investigates the existence of “reversals” of association for recent mammography and describes an analysis strategy for identifying variables that might produce them.

Methods

We used every-other-year data for women aged 40–80 from the 1996–2006 Behavioral Risk Factor Surveillance System and the 1999, 2000, 2003, and 2005 National Health Interview Survey. A consistent set of covariates was used across all datasets.

Results

Reversals were found in almost all survey years for Hispanic women. Non-Hispanic Black women often had unadjusted rates comparable to Non-Hispanic Whites, but their adjusted odds ratios were significantly higher in most surveys. A limited number of variables contributed strongly to reversals, and differed somewhat for Hispanic and Black women.

Conclusions

Reversed associations found in adjusted analyses present a challenge for interpretation, but could also denote success of programs to increase screening rates. Users of population-level surveys should be alert for reversals and attempt to find explanations.
Literatur
2.
Zurück zum Zitat Curry SJ, Byers T, Hewitt M (eds) (2003) Fulfilling the potential for cancer prevention and early detection. National Academies Press, Washington, DC Curry SJ, Byers T, Hewitt M (eds) (2003) Fulfilling the potential for cancer prevention and early detection. National Academies Press, Washington, DC
4.
Zurück zum Zitat Rakowski W, Clark MA, Truchil R, Schneider K, Meersman S (2005) Smoking status and mammography among women aged 50–75 in the 2002 behavioral risk factor surveillance system. Women Health 41:1–21. doi:10.1300/J013v41n04_01 PubMed Rakowski W, Clark MA, Truchil R, Schneider K, Meersman S (2005) Smoking status and mammography among women aged 50–75 in the 2002 behavioral risk factor surveillance system. Women Health 41:1–21. doi:10.​1300/​J013v41n04_​01 PubMed
5.
Zurück zum Zitat Rakowski W, Meissner H, Vernon SE, Breen N, Rimer B, Clark MA (2006) Correlates of repeat and recent mammography for women aged 45–75 in the 2002–2003 Health Information and National Trends Survey (HINTS 2003). Cancer Epidemiol Biomarkers Prev 15:2093–2101. doi:10.1158/1055-9965.EPI-06-0301 PubMedCrossRef Rakowski W, Meissner H, Vernon SE, Breen N, Rimer B, Clark MA (2006) Correlates of repeat and recent mammography for women aged 45–75 in the 2002–2003 Health Information and National Trends Survey (HINTS 2003). Cancer Epidemiol Biomarkers Prev 15:2093–2101. doi:10.​1158/​1055-9965.​EPI-06-0301 PubMedCrossRef
6.
Zurück zum Zitat Ostbye T, Greenberg GN, Taylor DH Jr, Lee AM (2003) Screening mammography and Pap tests among older American women 1996–2000: results from the health and retirement study (HRS) and asset and health dynamics among the oldest old (AHEAD). Ann Fam Med 1:209–217. doi:10.1370/afm.54 PubMedCrossRef Ostbye T, Greenberg GN, Taylor DH Jr, Lee AM (2003) Screening mammography and Pap tests among older American women 1996–2000: results from the health and retirement study (HRS) and asset and health dynamics among the oldest old (AHEAD). Ann Fam Med 1:209–217. doi:10.​1370/​afm.​54 PubMedCrossRef
7.
Zurück zum Zitat Martin LA, Wingo PA, Calle EE, Heath CW Jr (1996) Comparison of mammography and Pap test use from the 1987 and 1992 National Health Interview Surveys: are we closing the gaps? Am J Prev Med 12:82–90PubMed Martin LA, Wingo PA, Calle EE, Heath CW Jr (1996) Comparison of mammography and Pap test use from the 1987 and 1992 National Health Interview Surveys: are we closing the gaps? Am J Prev Med 12:82–90PubMed
10.
Zurück zum Zitat Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R (2001) Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 93:1704–1713. doi:10.1093/jnci/93.22.1704 PubMedCrossRef Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R (2001) Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 93:1704–1713. doi:10.​1093/​jnci/​93.​22.​1704 PubMedCrossRef
12.
Zurück zum Zitat Sallis JF, Owen N (2002) Ecological models of health behavior. In: Glanz K, Rimer BK, Lewis FM (eds) Health behavior and health education: theory, research, and practice, 3rd edn. Jossey-Bass, San Francisco, pp 462–484 Sallis JF, Owen N (2002) Ecological models of health behavior. In: Glanz K, Rimer BK, Lewis FM (eds) Health behavior and health education: theory, research, and practice, 3rd edn. Jossey-Bass, San Francisco, pp 462–484
13.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2008) Behavioral risk factor surveillance system operational and user’s guide version 3.0 December 12, 2006. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta. ftp://ftp.cdc.gov/pub/Data/Brfss/userguide.pdf. Accessed 23 June 2008 Centers for Disease Control and Prevention (CDC) (2008) Behavioral risk factor surveillance system operational and user’s guide version 3.0 December 12, 2006. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta. ftp://​ftp.​cdc.​gov/​pub/​Data/​Brfss/​userguide.​pdf. Accessed 23 June 2008
15.
Zurück zum Zitat Mokdad AH, Stroup DF, Giles WH (2003) Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Recomm Rep 52:1–12PubMed Mokdad AH, Stroup DF, Giles WH (2003) Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Recomm Rep 52:1–12PubMed
16.
Zurück zum Zitat Centers for Disease Control, Prevention (CDC), National Center for Health Statistics (1999) National Health Interview Survey: research for the 1995–2004 redesign. Vital Health Stat 2:1–119 Centers for Disease Control, Prevention (CDC), National Center for Health Statistics (1999) National Health Interview Survey: research for the 1995–2004 redesign. Vital Health Stat 2:1–119
17.
Zurück zum Zitat Centers for Disease Control, Prevention (CDC), National Center for Health Statistics (2000) Design and estimation for the National Health Interview Survey, 1995–2004. Vital Health Stat 2:1–31 Centers for Disease Control, Prevention (CDC), National Center for Health Statistics (2000) Design and estimation for the National Health Interview Survey, 1995–2004. Vital Health Stat 2:1–31
20.
Zurück zum Zitat Research Triangle Institute (2005) SUDAAN, Release 9.0.1. Research Triangle Institute, Research Triangle Park, NC Research Triangle Institute (2005) SUDAAN, Release 9.0.1. Research Triangle Institute, Research Triangle Park, NC
21.
Zurück zum Zitat Rothman JK, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott Williams & Wilkins, Phildelphia, pp 255–259 Rothman JK, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott Williams & Wilkins, Phildelphia, pp 255–259
22.
24.
Zurück zum Zitat Wolters CL (2004) On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev 13:620–630PubMed Wolters CL (2004) On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev 13:620–630PubMed
25.
Zurück zum Zitat Adams EK, Breen N, Joski PJ (2007) Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996–2000. Cancer 109(2 Suppl):348–358. doi:10.1002/cncr.22353 PubMedCrossRef Adams EK, Breen N, Joski PJ (2007) Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996–2000. Cancer 109(2 Suppl):348–358. doi:10.​1002/​cncr.​22353 PubMedCrossRef
Metadaten
Titel
Investigating reversals of association for utilization of recent mammography among Hispanic and Non-Hispanic Black women
verfasst von
William Rakowski
Melissa A. Clark
Michelle L. Rogers
Sherry Weitzen
Publikationsdatum
01.10.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 8/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9345-8

Weitere Artikel der Ausgabe 8/2009

Cancer Causes & Control 8/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.